2011/91/EU: Commission Decision of 10 February 2011 authorising a laboratory in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines (notified under document C(2011) 656) Text with EEA relevance

• Articles: 3

Article 1

In accordance with Article 3(2) of Decision 2000/258/EC, the following laboratory is authorised to perform the serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets:

Komipharm International Co. Ltd

1236-6 Jeoungwang-dong

420-450 Siheung-si, Gyeonggi-do

South Korea

Article 2

This Decision shall apply from 1 March 2011.

Article 3

This Decision is addressed to the Member States.